-
The Future of Breast Cancer Screening?
At Waters, we’re constantly innovating our mass spectrometry systems to improve human health, like this groundbreaking advance in breast cancer detection.
Recent Posts
Accelerate Complex Materials Formulation Screening with Mass Spectrometry Analysis
Advanced materials companies are using direct mass spectrometry analysis to provide deeper insights into research, development and manufacturing processes.
Turning Energy, Passion, and Allyship into Action and Outcomes: Perfect Score from the Human Rights Campaign Foundation
Waters has been named one of the best places to work for LGBTQ+ equality. Waters received the highest score of 100% rating on the 2022 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s annual scorecard for LGBTQ+ workplace equality.
Helping Laboratories Embrace New Era of Efficiency
The new waters_connect for quantitation software, including the new MS Quan app – is designed to allow labs to increase productivity and harness the full potential of their lab.
Validation of Our Sustainability Efforts
Dow Jones Sustainability Index membership serves as a testament to our enterprise-wide commitment to enhance human health and wellbeing.
The Jim Waters Society Inductees Reflect Inventive Achievement
Four new Jim Waters Society inductees represent Waters' top scientists and engineers for remarkable achievements.
Attribute Monitoring Workflows [Infographic]
Learn how the BioAccord LC-MS System is instrumental in the drug development workflow from sample prep to reporting.
Popular Topics
ACQUITY QDa (16) bioanalysis (11) biologics (14) biopharma (26) biopharmaceutical (36) biosimilars (11) biotherapeutics (16) case study (16) chromatography (14) data integrity (21) food analysis (12) HPLC (15) LC-MS (21) liquid chromatography (LC) (19) mass detection (15) mass spectrometry (MS) (54) method development (13) STEM (12)